Reza Nejati, MD, Joins Department of Pathology at Fox Chase Cancer Center

Reza Nejati, MD
Reza Nejati, MD

PHILADELPHIA (August 15, 2017) – Fox Chase Cancer Center is pleased to announce the hiring of Reza Nejati, MD, as a hematopathologist in the Department of Pathology.

“Fox Chase Cancer Center provides innovative care with compassion and strives to develop cutting-edge therapies for patients,” said Nejati. “I look forward to joining my new colleagues in delivering this high standard of care.”

Nejati comes to Fox Chase from the University of Pennsylvania, where he completed a fellowship in hematopathology. He received his medical degree from Tehran University of Medical Sciences in Tehran, Iran, and he completed his residency training in anatomical and clinical pathology at both Iran University of Medical Sciences and the University of Tennessee Health Science Center. Nejati completed a surgical pathology fellowship at MD Anderson Cancer Center and is Board Certified in Anatomical and Clinical Pathology.

“Dr. Nejati brings a depth of knowledge and international scope that will benefit our team here at Fox Chase,” said Arthur Patchefsky, MD, chair of the Department of Pathology. “His experience, both here in the United States and internationally, is a key asset to the growth and direction our department strives for.”

Nejati will start his new role at Fox Chase on August 15, 2017.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text